Medicines Australia announce the resignation of CEO, Milton Catelin
Medicines Australia CEO Milton Catelin today announced his resignation from the peak body representing the innovative medicines industry, ahead of a move back to the United Kingdom (UK).
Medicines Australia Chairman Wes Cook thanked Milton, stating, “On behalf of the Board and our members I would like to thank Milton Catelin for his contribution to the innovative medicines industry.”
‘Milton is leaving Medicines Australia following a period of significant transformation and growth for our sector.”
“As an industry body we have benefited from his leadership of a highly experienced team who together have delivered meaningful health policy outcomes, for example the successful negotiation of the modification of the Government’s skilled migration occupation lists.”
“Milton has also worked closely with the members of the Medicines Australia secretariat and member companies to build strong and meaningful partnerships with our stakeholders, culminating in the highly engaging PharmAus event at Parliament House in September last year”, Mr Cook said.
Milton Catelin thanked the Board for their support over the past 18 months.
“As a group of highly engaged Managing Directors, they have worked cohesively to support myself and the secretariat to achieve some outstanding outcomes,” said Mr Catelin.
“I leave medicines Australia and the innovative medicines industry at a time of great strength. We’ve worked hard to establish the Strategic Agreement and developed firm partnerships with Government. Importantly, we have also mobilised and united as a membership like never before,” he said.
“I am privileged to have been able to contribute to this extraordinary sector,”
“I’d also like to thank the MA secretariat and wider membership for their commitment. Throughout my tenure, I have witnessed a passion and dedication that highlights how meaningful this industry is to the health of Australians,” Mr Catelin said.
Looking forward, Mr Cook said, “Today, with a highly engaged membership and experienced Secretariat, Medicines Australia is incredibly well positioned to contribute to the development of good health policy in Australia.
“I sincerely wish Milton all the very best on his future and his important move back to the UK to join his family,” concluded Mr Cook.
A sub-committee of the Medicines Australia Board will now commence a process to recruit a new CEO.
More information: Natalie Wimmer – Communications Manager, Medicines Australia
Ph: 0450 728 660